Needham & Company Maintains a 'Strong Buy' on Mylan (MYL); Receives Final Approval for Generic Oracea Potentially Setting Up Exclusivity Launch
Tweet Send to a Friend
Needham & Company maintains a 'Strong Buy' rating on Mylan Inc. (NYSE: MYL), price target $26.
Needham analyst says, "MYL ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Needham analyst says, "MYL ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
